DORIONNE WARREN: Open Payments
NPI 1578923124 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,846 in 199 payments from 21 companies in 2025. Trend: 2023 $4,210 · 2024 $3,708 · 2025 $4,846
Food & beverage: $4,733Education: $114
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 60 | $1,155 |
| AstraZeneca Pharmaceuticals LP | 27 | $1,022 |
| GENZYME CORPORATION | 24 | $628 |
| Regeneron Healthcare Solutions, Inc. | 21 | $444 |
| Grifols USA, LLC | 14 | $303 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $200 |
| Viatris Specialty LLC | 9 | $172 |
| Verona Pharma, Inc. | 7 | $152 |
| Amgen Inc. | 9 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $121 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Prolastin-C Liquid, TRELEGY ELLIPTA, AIRSUPRA, GLASSIA, BREZTRI.
Industry payments across OH — which companies pay providers there.
